The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 01, 2022

Filed:

Sep. 03, 2014
Applicant:

Novimmune S.a., Geneva, CH;

Inventors:

Nicolas Fischer, Geneva, CH;

Giovanni Magistrelli, Cessy, FR;

Francois Rousseau, Collonges sous Saleve, FR;

Krzysztof Masternak, Mollens, CH;

Pauline Malinge, Cernex, FR;

Assignee:

NovImmune SA, Geneva, CH;

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07K 16/46 (2006.01); C07K 16/28 (2006.01); C07K 16/24 (2006.01);
U.S. Cl.
CPC ...
C07K 16/468 (2013.01); C07K 16/244 (2013.01); C07K 16/2809 (2013.01); C07K 2317/21 (2013.01); C07K 2317/31 (2013.01); C07K 2317/50 (2013.01); C07K 2317/522 (2013.01); C07K 2317/526 (2013.01); C07K 2317/622 (2013.01); C07K 2317/94 (2013.01);
Abstract

The invention provides heterodimer bispecific antigen-binding molecules that include a first polypeptide that does not include an IgG CH1 domain and a second polypeptide where there is at least one mutation in the IgG CH3 domain that abolishes the ability of the second polypeptide to bind CH3-specific affinity media such that the first and second polypeptides have different affinities with respect to CH1 and CH3 specific affinity reagents that allows rapid isolation by differential binding. The invention also provides bispecific antibodies that have CH1 and CH3 regions with different affinities with respect to affinity reagents that allows rapid isolation by differential binding. The invention also concerns bispecific antibodies which are heterodimers of two IgG heavy chains that differ by at least two amino acids that allow for rapid isolation based on a differential affinity of one mutated heavy chain and a second mutated heavy chain toward two different affinity reagents.


Find Patent Forward Citations

Loading…